Molecular Templates Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Molecular Templates.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 30% Share Price Rise
Oct 10
Earnings Release: Here's Why Analysts Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Price Target To US$18.00
Aug 17Molecular Templates, Inc.'s (NASDAQ:MTEM) Shares Bounce 27% But Its Business Still Trails The Industry
Jul 30Little Excitement Around Molecular Templates, Inc.'s (NASDAQ:MTEM) Revenues As Shares Take 48% Pounding
Apr 03Lacklustre Performance Is Driving Molecular Templates, Inc.'s (NASDAQ:MTEM) 26% Price Drop
Dec 20There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 45% Share Price Rise
Apr 17What Does The Future Hold For Molecular Templates, Inc. (NASDAQ:MTEM)? These Analysts Have Been Cutting Their Estimates
Nov 16Time To Worry? Analysts Are Downgrading Their Molecular Templates, Inc. (NASDAQ:MTEM) Outlook
Aug 14Molecular Templates GAAP EPS of -$0.44 misses by $0.01, revenue of $4.42M misses by $2.6M
Aug 11Rock star Growth Puts Molecular Templates (NASDAQ:MTEM) In A Position To Use Debt
Apr 29Health Check: How Prudently Does Molecular Templates (NASDAQ:MTEM) Use Debt?
Dec 30Some Analysts Just Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates
Nov 25Is Molecular Templates (NASDAQ:MTEM) Using Debt In A Risky Way?
Sep 22News Flash: Analysts Just Made A Notable Upgrade To Their Molecular Templates, Inc. (NASDAQ:MTEM) Forecasts
Aug 15Need To Know: Analysts Just Made A Substantial Cut To Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates
May 18Brokers Are Upgrading Their Views On Molecular Templates, Inc. (NASDAQ:MTEM) With These New Forecasts
Mar 21Need To Know: The Consensus Just Cut Its Molecular Templates, Inc. (NASDAQ:MTEM) Estimates For 2021
Feb 21Is Molecular Templates (NASDAQ:MTEM) A Risky Investment?
Jan 26
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Molecular Templates has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 25 | -16 | -24 | -24 | N/A |
| 3/31/2024 | 32 | -18 | -28 | -28 | N/A |
| 12/31/2023 | 57 | -8 | -42 | -42 | N/A |
| 9/30/2023 | 53 | -26 | -55 | -55 | N/A |
| 6/30/2023 | 50 | -47 | -73 | -72 | N/A |
| 3/31/2023 | 48 | -60 | -84 | -81 | N/A |
| 12/31/2022 | 20 | -93 | -92 | -89 | N/A |
| 9/30/2022 | 35 | -81 | -97 | -93 | N/A |
| 6/30/2022 | 33 | -87 | -98 | -93 | N/A |
| 3/31/2022 | 44 | -78 | -104 | -100 | N/A |
| 12/31/2021 | 39 | -83 | -34 | -30 | N/A |
| 9/30/2021 | 24 | -101 | -35 | -29 | N/A |
| 6/30/2021 | 26 | -94 | -30 | -24 | N/A |
| 3/31/2021 | 18 | -110 | -30 | -23 | N/A |
| 12/31/2020 | 19 | -105 | -91 | -84 | N/A |
| 9/30/2020 | 22 | -92 | -56 | -48 | N/A |
| 6/30/2020 | 21 | -107 | -57 | -45 | N/A |
| 3/31/2020 | 19 | -85 | -42 | -32 | N/A |
| 12/31/2019 | 22 | -69 | -35 | -25 | N/A |
| 9/30/2019 | 21 | -60 | -27 | -20 | N/A |
| 6/30/2019 | 24 | -27 | -16 | -13 | N/A |
| 3/31/2019 | 20 | -28 | -11 | -6 | N/A |
| 12/31/2018 | 13 | -30 | -10 | -4 | N/A |
| 9/30/2018 | 9 | -31 | -38 | -32 | N/A |
| 6/30/2018 | 3 | -36 | -32 | -26 | N/A |
| 3/31/2018 | 2 | -31 | N/A | -21 | N/A |
| 12/31/2017 | 3 | -24 | N/A | -14 | N/A |
| 9/30/2017 | 3 | -20 | N/A | -7 | N/A |
| 6/30/2017 | 2 | -13 | N/A | -6 | N/A |
| 3/31/2017 | 3 | -11 | N/A | -10 | N/A |
| 12/31/2016 | 2 | -13 | N/A | -9 | N/A |
| 12/31/2015 | 1 | -7 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MTEM's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if MTEM's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if MTEM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MTEM's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if MTEM's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MTEM's Return on Equity is forecast to be high in 3 years time